COMPASS PATHWAYS PLC Shareholders' Equity
COMPASS PATHWAYS PLC (CMPS) had Shareholders' Equity of $84.53 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $84.53M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $326.69M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$52.85M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $37.59M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $84.53M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $326.69M 10-Q · filed 2026-08-05 |
| 2025-12-31 | -$52.85M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $37.59M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $162.56M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $195.47M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $154.69M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $193.03M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $226.27M 10-Q · filed 2025-11-04 |
| 2024-03-31 | $259.16M 10-Q · filed 2025-11-04 |
| 2023-12-31 | $225.74M 10-K · filed 2026-03-24 |
| 2023-09-30 | $253.25M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $166.40M 10-Q · filed 2024-10-31 |
| 2023-03-31 | $161.64M 10-Q · filed 2024-10-31 |
| 2022-12-31 | $181.28M 10-K · filed 2025-02-27 |
| 2022-09-30 | $194.56M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $224.59M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $259.57M 10-Q · filed 2023-11-02 |
| 2021-12-31 | $284.41M 10-K · filed 2024-02-29 |
| 2021-09-30 | $305.42M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $327.36M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $188.50M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $196.56M 10-K · filed 2024-02-29 |
| 2020-09-30 | $203.07M 6-K · filed 2021-11-09 |
| 2020-06-30 | -$44.85M 6-K · filed 2021-11-09 |
| 2020-03-31 | -$37.62M 6-K · filed 2021-11-09 |
| 2019-12-31 | -$30.39M 10-K · filed 2023-02-28 |
| 2018-12-31 | -$14.37M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |